Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST-HP: Tegoprazan Dual Therapy Dosing
NCT07242443Phase 4Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Nov 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tegoprazan in Helicobacter pylori infection (2 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Helicobacter pylori Eradication Rate. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07242443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07242443.